ESMO Congress 2024 ESMO 2024: Intracranial Activity of T-DXd in HER2-Positive Metastatic Breast Cancer
Breast Cancer Addition of Sacituzumab Govitecan to Pembrolizumab in Advanced Triple-Negative Breast Cancer